Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Hikma agrees to acquires Roxane Laboratories for $1.18bn Hikma Pharmaceuticals, the fast growing multinational pharmaceutical group, announces that it has agreed to acquire Roxane Laboratories and Boehringer Ingelheim Roxane (together, Roxane), from Boehringer Ingelheim.
Production & Manufacturing > Manufacturing > News
Merck improves immuno-oncology portfolio with acquisition of cCAM Biotherapeutics Merck, known as MSD outside the United States and Canada, and cCAM Biotherapeutics announced that the companies have signed a definitive agreement under which Merck will acquire cCAM Biotherapeutics, a privately held biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies.
Production & Manufacturing > Manufacturing > News Teva agrees to buy Allergan Generics for $40.5bn By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries has signed a definitive agreement to acquire Irish pharmaceutical firm Allergan's generic drugs unit in a transaction valued at $40.5bn.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Truly Parallel - Cell Culture
| By Eppendorf
DASGIP® Bioreactor Systems for Cell Culture Applications.
Production & Manufacturing > Manufacturing > White Papers
Product Brochure: Most Compact
| By Eppendorf
DASbox® Mini Bioreactor System for Cell Culture and Microbiology.
Production & Manufacturing > Manufacturing > White Papers
Teva agrees to buy Allergan Generics for $40.5bn
By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries has signed a definitive agreement to acquire Irish pharmaceutical firm Allergan's generic drugs unit in a transaction valued at $40.5bn.
Production & Manufacturing > Manufacturing > News
Teva Parenteral Medicines begins recall of Select Lots of Adrucil 5g/100mL due to particulate matter
Teva Parenteral Medicines today announced a voluntary recall of six lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.
Production & Manufacturing > Manufacturing > News
Allergan agrees to acquire Naurex for $560m
By PBR Staff Writer
Irish pharmaceutical firm Allergan has agreed to acquire US-based biopharmaceutical company Naurex for around $560m.
Production & Manufacturing > Manufacturing > News
Johnson & Johnson to challenge Novartis in axial spondyloarthrtis treatment space, says GlobalData
Johnson & Johnson’s (J&J) psoriasis drug, Stelara, has progressed into Phase III development for axial spondyloarthritis (axSpA) and, following its anticipated approval, is forecast to achieve impressive axSpA sales of $244.7 million in 2024, says research and consulting firm GlobalData.
Production & Manufacturing > Manufacturing > News
Valeant to buy Amoun Pharmaceutical for $800m
By PBR Staff Writer
Valeant Pharmaceuticals International has entered into a definitive agreement to acquire Mercury (Cayman) Holdings, the holding company of Egyptian drug-maker Amoun Pharmaceutical, for $800m, including contingent payments.
Production & Manufacturing > Manufacturing > News
Eisai agrees to transfer North Carolina manufacturing facility to Biogen
By PBR Staff Writer
Japanese pharmaceutical firm Eisai's US subsidiary Eisai has entered into a definitive agreement to transfer ownership of its Research Triangle Park (RTP)-based manufacturing facility in North Carolina to Biogen.
Production & Manufacturing > Manufacturing > News
Celgene agrees to acquire Receptos for $7.2bn
By PBR Staff Writer
US-based biopharmaceutical firm Celgene is expanding its inflammation and immunology (I&I) portfolio by agreeing to acquire Receptos, for around $7.2bn.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests